FIELD: medicine.
SUBSTANCE: invention can be used in such areas as therapy, general medical practice, cardiology, functional diagnostics. A 12-channel ECG is registered and the electrocardiographic characteristic of the P wave — the time from the beginning of the descending limb of the first positive wave of the “p” wave (p1) to the beginning of the descending limb of the second positive wave of the “p” wave (p2) is assessed, if it is equal to or greater than 35 ms then there is the risk of developing atrial fibrillation.
EFFECT: expanding the range of technical means and simplification of the assessment of the conduction of excitation in the atria, which allows to increase the identification of patients at risk of developing atrial fibrillation, in order to carry out timely preventive measures for arrhythmogenic strokes.
1 cl, 7 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING ELECTROPHYSIOLOGICAL CHARACTERISTICS OF ATRIAL EXCITATION | 2022 |
|
RU2821777C2 |
| METHOD FOR EVALUATING INTRA-ATRIAL AND INTER-ATRIAL STIMULATION PROCESS | 2004 |
|
RU2271144C2 |
| METHOD FOR PREDICTING THE ONSET OF PAROXYSMAL ATRIAL FIBRILLATION | 2004 |
|
RU2290060C2 |
| METHOD FOR DETERMINING RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH PREMATURE ATRIAL CONTRACTION | 2014 |
|
RU2556602C1 |
| METHOD OF DETERMINING RISK OF ATRIUM FIBRILLATION DEVELOPMENT | 2012 |
|
RU2497446C1 |
| METHOD FOR DETERMINING THE RISK DEVELOPMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH PREMATURE ATRIAL CONTRACTION | 2017 |
|
RU2657189C1 |
| METHOD FOR PREDICTION OF NATURAL CLINICAL COURSE OF SHORT PQ INTERVAL PHENOMENON | 2014 |
|
RU2560776C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF MODULATED KINESITHERAPY AS A PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL EXTRASYSTOLE | 2017 |
|
RU2667827C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL EXTRASYSTOLE | 2021 |
|
RU2763978C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF THE PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN THE PATIENTS WITH ATRIAL EXTRASYSTOLE | 2018 |
|
RU2688394C1 |
